U.S. flag

An official website of the United States government

NM_001370658.1(BTD):c.1372G>A (p.Ala458Thr) AND Biotinidase deficiency

Germline classification:
Conflicting interpretations of pathogenicity (4 submissions)
Last evaluated:
Mar 29, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000022034.12

Allele description [Variation Report for NM_001370658.1(BTD):c.1372G>A (p.Ala458Thr)]

NM_001370658.1(BTD):c.1372G>A (p.Ala458Thr)

Gene:
BTD:biotinidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p25.1
Genomic location:
Preferred name:
NM_001370658.1(BTD):c.1372G>A (p.Ala458Thr)
HGVS:
  • NC_000003.12:g.15645288G>A
  • NG_008019.2:g.48937G>A
  • NG_008019.3:g.48938G>A
  • NM_000060.4:c.1432G>A
  • NM_001281723.4:c.1372G>A
  • NM_001281724.3:c.1372G>A
  • NM_001281725.3:c.1372G>A
  • NM_001323582.2:c.1372G>A
  • NM_001370658.1:c.1372G>AMANE SELECT
  • NM_001370752.1:c.1015+357G>A
  • NM_001370753.1:c.399+3231G>A
  • NM_001407364.1:c.1372G>A
  • NM_001407365.1:c.1372G>A
  • NM_001407366.1:c.1372G>A
  • NM_001407367.1:c.1372G>A
  • NM_001407368.1:c.1372G>A
  • NM_001407369.1:c.1372G>A
  • NM_001407370.1:c.1372G>A
  • NM_001407371.1:c.1372G>A
  • NM_001407372.1:c.1372G>A
  • NM_001407373.1:c.1372G>A
  • NM_001407374.1:c.1372G>A
  • NM_001407375.1:c.1372G>A
  • NM_001407376.1:c.1372G>A
  • NM_001407377.1:c.1372G>A
  • NM_001407378.1:c.1372G>A
  • NP_000051.1:p.Ala478Thr
  • NP_001268652.2:p.Ala458Thr
  • NP_001268652.2:p.Ala458Thr
  • NP_001268653.2:p.Ala458Thr
  • NP_001268654.1:p.Ala458Thr
  • NP_001268654.1:p.Ala458Thr
  • NP_001310511.1:p.Ala458Thr
  • NP_001310511.1:p.Ala458Thr
  • NP_001357587.1:p.Ala458Thr
  • NP_001394293.1:p.Ala458Thr
  • NP_001394294.1:p.Ala458Thr
  • NP_001394295.1:p.Ala458Thr
  • NP_001394296.1:p.Ala458Thr
  • NP_001394297.1:p.Ala458Thr
  • NP_001394298.1:p.Ala458Thr
  • NP_001394299.1:p.Ala458Thr
  • NP_001394300.1:p.Ala458Thr
  • NP_001394301.1:p.Ala458Thr
  • NP_001394302.1:p.Ala458Thr
  • NP_001394303.1:p.Ala458Thr
  • NP_001394304.1:p.Ala458Thr
  • NP_001394305.1:p.Ala458Thr
  • NP_001394306.1:p.Ala458Thr
  • NP_001394307.1:p.Ala458Thr
  • NC_000003.11:g.15686795G>A
  • NM_001281723.3:c.1372G>A
  • NM_001281725.2:c.1372G>A
  • NM_001323582.1:c.1372G>A
  • NM_001370658.1:c.1372G>A
Protein change:
A458T
Links:
dbSNP: rs181396238
NCBI 1000 Genomes Browser:
rs181396238
Molecular consequence:
  • NM_001370752.1:c.1015+357G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001370753.1:c.399+3231G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000060.4:c.1432G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281723.4:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281724.3:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281725.3:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001323582.2:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001370658.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407364.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407365.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407366.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407367.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407368.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407369.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407370.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407371.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407372.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407373.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407374.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407375.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407376.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407377.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001407378.1:c.1372G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Biotinidase deficiency
Synonyms:
BTD deficiency; Late-onset biotin-responsive multiple carboxylase deficiency; Biotin deficiency
Identifiers:
MONDO: MONDO:0009665; MedGen: C0220754; Orphanet: 79241; OMIM: 253260

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000800692Counsyl
criteria provided, single submitter

(Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018))
Uncertain significance
(Apr 12, 2018)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link,

SCV000963906Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 25, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV001461226Natera, Inc.
no assertion criteria provided
Uncertain significance
(Sep 16, 2020)
germlineclinical testing

SCV004211395Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Mar 29, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Forty-eight novel mutations causing biotinidase deficiency.

Procter M, Wolf B, Mao R.

Mol Genet Metab. 2016 Mar;117(3):369-72. doi: 10.1016/j.ymgme.2016.01.002. Epub 2016 Jan 12.

PubMed [citation]
PMID:
26810761

High incidence of profound biotinidase deficiency detected in newborn screening blood spots in the Somalian population in Minnesota.

Sarafoglou K, Bentler K, Gaviglio A, Redlinger-Grosse K, Anderson C, McCann M, Bloom B, Babovic-Vuksanovic D, Gavrilov D, Berry SA.

J Inherit Metab Dis. 2009 Dec;32 Suppl 1:S169-73. doi: 10.1007/s10545-009-1135-7. Epub 2009 Sep 7.

PubMed [citation]
PMID:
19757147
See all PubMed Citations (4)

Details of each submission

From Counsyl, SCV000800692.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000963906.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 478 of the BTD protein (p.Ala478Thr). This variant is present in population databases (rs181396238, gnomAD 0.01%). This missense change has been observed in individual(s) with biotinidase deficiency (PMID: 26810761). ClinVar contains an entry for this variant (Variation ID: 25108). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BTD protein function with a positive predictive value of 95%. This variant disrupts the p.Ala478 amino acid residue in BTD. Other variant(s) that disrupt this residue have been observed in individuals with BTD-related conditions (PMID: 19757147), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV001461226.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004211395.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024